Cipla stock tanks 8% after USFDA warning over issues at MP unit

[ad_1] Shares of pharma giant Cipla Ltd plunged as much as 8% to hit an intraday low of ₹1165.10 apiece on BSE after the United States Food and Drug Administration (USFDA)…